Name | N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide |
---|---|
Synonyms |
Avosentan
UNII-L94KSX715K 2-Pyridinesulfonamide, N-[6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl- N-[6-Methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl-2-pyridinesulfonamide Ro 67-0565 SPP301 |
Description | Avosentan(Ro 67-0565; SPP-301) is a potent, selective endothelin receptor(ETA receptor) antagonist.IC50 value:Target: ETA receptor |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 575.5±60.0 °C at 760 mmHg |
Molecular Formula | C23H21N5O5S |
Molecular Weight | 479.508 |
Flash Point | 301.8±32.9 °C |
Exact Mass | 479.126343 |
PSA | 133.80000 |
LogP | 0.87 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.621 |
Storage condition | 2-8℃ |
~% 290815-26-8 |
Literature: Hoffmann-La Roche Inc. Patent: US6417360 B1, 2002 ; |
Precursor 1 | |
---|---|
DownStream 0 |